Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Tenet Healthcare Corp    THC

TENET HEALTHCARE CORP

(THC)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
The feature you requested does not exist. However, we suggest the following feature:

Tenet Healthcare : to Report Second Quarter Results on August 5

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/08/2019 | 08:04am EDT

Tenet Healthcare Corporation (NYSE: THC) plans to report results for its second quarter ended June 30, 2019 after the market close on Monday, August 5, 2019.

The company will host a conference call the following morning, Tuesday, August 6, at 10:00 a.m. ET (9:00 a.m. CT) for management to discuss the results. A live webcast and accompanying presentation will be accessible through the investor relations section of Tenet’s website at www.tenethealth.com/investors. Shortly after the conference call, a replay of the webcast will be available on the website.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a national diversified healthcare services company headquartered in Dallas, TX, with 110,000 employees. Through an expansive care network that includes United Surgical Partners International, we operate 65 hospitals and approximately 500 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers and other outpatient facilities. We also operate Conifer Health Solutions, which provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers and other customers. At the center of everything we do is a commitment to deliver the right care, in the right place, at the right time, and to continually improve and advance the healthcare delivery system in the markets we serve. For more information, please visit www.tenethealth.com.

The terms “THC”, “Tenet Healthcare Corporation”, “the company”, “we”, “us” or “our” refer to Tenet Healthcare Corporation or one or more of its subsidiaries or affiliates as applicable.

Tenet uses its company website to provide important information to investors about the company including the posting of important announcements regarding financial performance and corporate developments.


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on TENET HEALTHCARE CORP
07/08TENET HEALTHCARE : to Report Second Quarter Results on August 5
BU
06/27TENET HEALTHCARE : Announces Results for 2019 Healthy Over Hungry® Cereal Drive
BU
06/24TENET HEALTHCARE : Conifer Health and Dartmouth-Hitchcock Health Expand Relation..
BU
06/24TENET HEALTHCARE : and Aetna Sign Multi-Year Agreement
BU
06/21TENET HEALTHCARE CORP : Change in Directors or Principal Officers (form 8-K)
AQ
06/20TENET HEALTHCARE : Announces Retirement of Keith Pitts
BU
06/08Tenet Board Appoints Chris Lynch as New Independent Director
AQ
06/06TENET HEALTHCARE CORP : Change in Directors or Principal Officers (form 8-K)
AQ
06/06TENET HEALTHCARE : Board Appoints Chris Lynch as New Independent Director
BU
06/04TENET HEALTHCARE : to Participate in the Barclays High Yield Bond & Syndicated L..
BU
More news
Financials (USD)
Sales 2019 18 194 M
EBIT 2019 1 851 M
Net income 2019 101 M
Debt 2019 14 411 M
Yield 2019 -
P/E ratio 2019 17,9x
P/E ratio 2020 6,67x
EV / Sales2019 0,90x
EV / Sales2020 0,85x
Capitalization 1 912 M
Chart TENET HEALTHCARE CORP
Duration : Period :
Tenet Healthcare Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TENET HEALTHCARE CORP
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Average target price 27,85  $
Last Close Price 18,54  $
Spread / Highest target 132%
Spread / Average Target 50,2%
Spread / Lowest Target 18,7%
EPS Revisions
Managers
NameTitle
Ronald A. Rittenmeyer Executive Chairman & Chief Executive Officer
Saumya Sutaria Chief Operating Officer
Daniel J. Cancelmi Chief Financial Officer
Octavio Diaz Chief Medical Officer
Paola Arbour Chief Information Officer & Senior Vice President